ADULTS WITH DRY EYE DISEASE HAVE A HIGH RATE OF LATENT GRAM-NEGATIVE BACTERIA IN THEIR CONJUNCTIVA
Main Article Content
Keywords
Adults, Eye, Disease, Gram-Negative Bacteria
Abstract
In youthful adults with parched eye disease, the prevalence of conjunctival C.trachomatis (CT), M. hominis (MH), and U. urealyticum (UU) contamination is investigated since these contamination may possible state contribute to long term subclinical illness. There were 57 subjects with DED (n = 57) and 49 subjects with non-dry eye control (n = 49) in the study. Self-recorded problem, bio microscopy, Schirmer I test, and division were used to diagnose the condition. The conjunctivas of all patients were scraped and analyzed with undeviating fluorescent to make a specific immune response assay equipment for the detection of CT, MH, and UU. DED patients were more likely to have at least one of the three microorganisms than controls, with 87.7% having at least one of the three. DED patients who had CT, MH, or UU infections accounted for 63.2%, 50.8%, and 42.1% of all cases. Infectious DED patients were found to have multiple pathogens in 65% of cases. Controls had a CT infection rate of 6.1%. A tall wave passing of C.trachomatis, M.hominis, and U.urealyticum was found in the conjunctiva of youthful adults with DED, suggesting that these infections could be significant risk factors for DED.
References
2. Rao, S. N. Topical cyclosporine 0.05% for the prevention of dry eye disease progression. J. Ocular Pharmacol. Ther. 2010, 26(2), 157–164. https://doi.org/10.1089/jop.2009.0119
3. Amparo, F.; Dastjerdi, M. H.; Okanobo, A.; et al. Topical interleukin 1 receptor antagonist for treatment of dry eye disease: A randomized clinical trial. J. Am. Med. Assoc. Ophthalmol. 2013, 131(6), 715–723. https://doi.org/10.1001/jamaophthalmol.2013.1929
4. Hom, M. M.; Nguyen, A. L.; Bielory, L. Allergic conjunctivitis and dry eye syndrome. Ann. Allergy Asthma Immunol. 2012, 108(3), 163–166. https://doi.org/10.1016/j.anai.2011.12.006
5. Beatty, W. L.; Byrne, G. I.; Morrison, R. P. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol. 1994, 2(3), 94–98. https://doi.org/10.1016/0966-842X(94)90079-4
6. Razin, S.; Yogev, D.; Naot, Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev. 1998, 62(4), 1094–1156. https://doi.org/10.1128/MMBR.62.4.1094-1156.1998
7. Baka, S.; Kouskouni, E.; Antonopoulou, S.; et al. Prevalence of Ureaplasma urealyticum and Mycoplasma hominis in women with chronic urinary symptoms. Urology 2009, 74(1), 62–66. https://doi.org/10.1016/j.urology.2009.02.051
8. McCormack, W. M. Epidemiology of Mycoplasma hominis. Sex. Transm. Dis. 1983, 10(4, Supplement), 261–262. https://doi.org/10.1097/00007435-198310000-00002
9. Goller, J. L.; Ward, J.; Saunders, M.; et al. Chlamydia sentinel surveillance in Aboriginal community controlled health services finds higher testing and positivity rates among younger people. Aust. N. Z. J. Public Health 2012, 36(6), 577–581. https://doi.org/10.1111/j.1753-6405.2012.00955.x
10. Salmeri, M.; Valenti, D.; la Vignera, S.; et al. Prevalence of Ureaplasma urealyticum and Mycoplasma hominis infection in unselected infertile men. J. Chemother. 2012, 24(2), 81–86. https://doi.org/10.1179/1973947812Y.0000000031
11. Malamos, P.; Georgalas, I.; Rallis, K.; et al. Evaluation of single-dose azithromycin versus standard azithromycin/doxycycline treatment and clinical assessment of regression course in patients with adult inclusion conjunctivitis. Curr. Eye Res. 2013, 38(12), 1198–1206. https://doi.org/10.3109/02713683.2013.833874
12. Bjo¨rnelius, E.; Jensen, J. S.; Lidbrink, P. Conjunctivitis associated with Mycoplasma genitalium infection. Clin. Infect. Dis. 2004, 39(7), e67–e69. https://doi.org/10.1086/423848
13. American Association for Research in Vision and Ophthalmology. Helsinki Declaration. https://www.arvo.org/About_ARVO/Policies/Helsinki_Declaration/.
14. Hindawi. ISRN Ophthalmology Guidelines. https://www.hindawi.com/journals/isrn.ophthalmology/guidelines/.
15. By, P.; Papp, J. R.; Schachter, J.; Gaydos, C. A.; van der Pol, B. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014. Morb. Mortal. Wkly. Rep. Recommendations Rep. 2014, 63(2), 1–19. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6302a1.htm
16. Sachdeva, P.; Patel, A. L.; Sachdev, D.; Ali, M.; Mittal, A.; Saluja, D. Comparison of an in-house PCR assay, direct fluorescence assay and the Roche AMPLICOR Chlamydia trachomatis kit for detection of C. trachomatis. J. Med. Microbiol. 2009, 58(7), 867–873. https://doi.org/10.1099/jmm.0.008342-0
17. Stamm, W. E.; Harrison, H. R.; Alexander, E. R.; Cles, L. D.; Spence, M. R.; Quinn, T. C. Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions: A multicenter trial. Ann. Intern. Med. 1984, 101(5), 638–641. https://doi.org/10.7326/0003-4819-101-5-638
18. Kiviat, N. B.; Wolner-Hanssen, P.; Peterson, M.; et al. Localization of Chlamydia trachomatis infection by direct immunofluorescence and culture in pelvic inflammatory disease. Am. J. Obstet. Gynecol. 1986, 154(4), 865–873. https://doi.org/10.1016/0002-9378(86)90212-7
19. Potts, M. J.; Paul, I. D.; Roome, A. P.; Caul, E. O. Rapid diagnosis of Chlamydia trachomatis infection in patients attending an ophthalmic casualty department. Br. J. Ophthalmol. 1986, 70(9), 677–680. https://doi.org/10.1136/bjo.70.9.677
20. Zigangirova, N. A.; Rumyantseva, Y. P.; Morgunova, E. Y.; et al. Detection of C. trachomatis in the serum of patients with urogenital chlamydiosis. BioMed. Res. Int. 2013, Article ID 489489, 7 pages. https://doi.org/10.1155/2013/489489
21. Patton, D. L.; Chan, K. Y.; Kuo, C.-C.; Cosgrove, Y. T.; Langley, L. In vitro growth of Chlamydia trachomatis in conjunctival and corneal epithelium. Invest. Ophthalmol. Vis. Sci. 1988, 29(7), 1087–1095. https://doi.org/10.1167/iovs.29.7.1087
22. Uchida, H.; Imanaga, Y. Effect of mild conjunctivitis complication on tear balance in dry eye. Contact Lens Anterior Eye 2012, 35(5), 240–242. https://doi.org/10.1016/j.clae.2012.06.002
23. Abdelsamed, H.; Peters, J.; Byrne, G. I. Genetic variation in Chlamydia trachomatis and their hosts: Impact on disease severity and tissue tropism. Future Microbiol. 2013, 8(9), 1129–1146. https://doi.org/10.2217/fmb.13.102
24. Hu, V. H.; Holland, M. J.; Burton, M. J. Trachoma: Protective and pathogenic ocular immune responses to Chlamydia trachomatis. PLoS Negl. Trop. Dis. 2013, 7(2), Article ID e2020. https://doi.org/10.1371/journal.pntd.0002020
25. Alves, M.; Angerami, R. N.; Rocha, E. M. Dry eye disease caused by viral infection: Review. Arq. Bras. Oftalmol. 2013, 76(2), 129–132. https://doi.org/10.5935/0004-2749.20130033
26. Akpek, E. K.; Klimava, A.; Thorne, J. E.; Martin, D.; Lekhanont, K.; Ostrovsky, A. Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. Cornea 2009, 28(5), 493–497. https://doi.org/10.1097/ICO.0b013e31818d62a4
27. Krásny´, J.; Hruba´, D.; Netukova´, M.; Kodat, V.; Pokorna´, J. Keratoconjunctivitis sicca during follicular conjunctivitis in adult patients with Chlamydia pneumoniae etiology (summarizing twelve years study). Ceska Slovenska Oftalmologie 2011, 67(2), 42, 44–48, 50. [Czech].
 
							